Adherence, HIV-1 Infection, Resistance, and Renal and Skeletal Adverse Event in Individuals Taking Truvada® for HIV Pre-Exposure Prophylaxis (PrEP)
Clinical trial NCT01906255 · COMPLETED
Trial details
- NCT number
- NCT01906255
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-10-07
- Primary completion
- 2021-04-27
- Enrollment
- 10577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.